Royal Bank Of Canada Inmune Bio, Inc. Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 48,782 shares of INMB stock, worth $118,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,782
Previous 29,863
63.35%
Holding current value
$118,052
Previous $233,000
51.93%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding INMB
# of Institutions
102Shares Held
6.32MCall Options Held
1.64MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA848KShares$2.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.97 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.44 Million45.87% of portfolio
-
Ubs Group Ag449KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$943,6330.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $43.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...